Herpes simplex virus type 1/adeno-associated virus (HSV/ AAV) rep + hybrid amplicon vectors containing AAV inverted terminal repeats (ITRs) and rep gene sequences can mediate site-specific integration into the human genome. In this study, we have generated and characterized the first transgenic mice that bear the full-length (8.2 kb) human AAVS1 locus. Immortalized mouse embryonic fibroblasts from this mouse line were transduced with the rep + , rep À (containing only ITRs flanking the transgene) hybrid amplicon vectors, and the standard amplicon vector to determine stable integration frequency and the site of integration. Transduction of transgenic fibroblasts resulted in a 10-fold higher stable integration frequency with rep + hybrid amplicon vector than with rep À or standard amplicon vectors. Southern blot analysis of genomic DNA from transgenic cells stably transduced with the rep + hybrid amplicon vector revealed site-specific integration of transgenes at the AAVS1 locus in 50% of clones. Some site-specific and random integration events were limited to the ITR-flanked transgene cassette. In contrast, transduction of transgenic mouse cells with the rep À or standard amplicon vectors resulted in random integrations of the entire rep À hybrid amplicon or amplicon DNA that were incorporated into the host genome as a concatenate of various sizes. These results demonstrate for the first time that the genome of transgenic mice bearing the human AAVS1 locus serves as a platform for site-specific integration of AAV ITR-flanked transgene cassettes within the hybrid amplicon vector in the presence of Rep.
Introduction
The HSV amplicon is a procaryotic plasmid that contains two noncoding DNA elements of herpes simplex virus type-1 (HSV-1): a viral DNA packaging signal (pac) and an origin of viral DNA replication (ori s ).
1,2 Both of these elements are necessary and sufficient to replicate and package the amplicon as a concatenate into virions in the presence of HSV-1 ''helper'' functions supplied by replicating virus, pac-deleted virus genomes, or a modified HSV-1 genome. [3] [4] [5] Amplicon vectors have many beneficial features for viral gene delivery, including a large transgene capacity (up to 153 kb), 6 low toxicity, and good transduction efficiency in many types of dividing and nondividing mammalian cells. [7] [8] [9] Adeno-associated virus (AAV) is a nonpathogenic parvovirus that, after infecting cells, can enter either a lytic or latent state. Efficient replication of the AAV genome occurs in the presence of coinfection with a helper virus, either adenovirus (Ad) or HSV. 10 However, low levels of helper-independent AAV replication can also occur in cells that are chemically synchronized to the S phase or exposed to toxic conditions, including UV irradiation, heat, or carcinogens. 11, 12 In the absence of a helper virus, the AAV genome can integrate into a specific AAVS1 site in the human host cell genome located on chromosome 19q13.3 and establish a latent infection. 13, 14 AAV has a single-stranded 4.7-kb DNA genome encoding four regulatory proteins (Rep40, 52, 68, 78) and three structural capsid proteins, and is flanked by 145-bp inverted terminal repeats (ITRs). 15 Both the ITRs and Rep68 or Rep78 proteins are essential for AAV replication and site-specific integration into the host genome. [16] [17] [18] When these Rep proteins are not expressed, the long-term expression of ITR-flanked cassettes is due to random integration(s) into the host chromosome(s) [19] [20] [21] and/or to its persistence as an extrachromosomal element. 22, 23 The large Rep proteins, in addition to being involved in the AAV life cycle, have also an effect on different viral and cellular gene expression at transcriptional and post-transcriptional levels. 24, 25 The exact mechanism of site-specific integration of AAV into the human genome is not completely understood; however, a few models based primarily on empirical work suggest that Rep proteins and specific elements present within ITRs and the AAVS1 site are involved. 26, 27 Importantly, only the AAVS1 sequence, and not the secondary structure of human chromosome 19, appears to be essential for AAV site-specific integration, because AAVS1 sequences introduced into either shuttle vectors 26 or animal genome 28, 29 can serve as platforms for site-specific integration of the AAV ITR-flanked cassette in the presence of Rep proteins. Two transgenic rodent models have been reported previously, which contain either a 3.5-kb fragment of the AAVS1 locus in the rat or mouse genome 28 or a 1.6-kb fragment in the mouse genome. 29 The HSV/AAV hybrid amplicon contains, in addition to the HSV-1 ori s and pac elements, either the AAV ITRs or the ITRs and the rep gene. 30 Thus far, several versions of the HSV/AAV hybrid amplicon vectors have been designed for targeted integration of transgenes into the human genome. One version that prolongs transgene expression in dividing and nondividing cells 31, 8 contains, through inadvertent construction, partial ITRs and interrupted rep sequences resulting in no expression of Rep proteins. Other versions contain full-length ITRs and the rep gene sequences that express either all four Rep proteins 32, 30 or the two large Rep proteins. 33 Both of these latter hybrid amplicon vectors have been shown to integrate the ITR-flanked transgene cassette into the AAVS1 locus in human cells in culture. 32, 33 In addition, the study by Wang et al 33 demonstrated the lack of sitespecific integrations of ITR-flanked cassette mediated by standard and rep À hybrid amplicon vectors in human cell lines. However, it has not been tested whether the backbone amplicon and rep À hybrid amplicon sequences also integrate into the host genome. While both Heister et al 32 and Wang et al 33 reported low titers of rep + hybrid amplicon vector, none of these studies have analyzed the vectors at the level of virion DNA.
The main goals of the present study were to generate a transgenic mice that carry the full-length (8.2 kb) human AAVS1 site 13 and to examine the frequency of integration events of a transgene delivered by HSV/AAV hybrid amplicon vectors (with and without the rep gene) into an immortalized mouse embryonic fibroblast line derived from these transgenic mice. Specifically, we evaluated the frequency of transgene integration into the AAVS1 site mediated by rep + hybrid amplicon vector. We also tested whether in addition to a transgene cassette, the backbone amplicon and rep À hybrid amplicon sequences integrate into the host genome in the stably transduced cells. Lastly, we assessed the size and integrity of amplicon and hybrid amplicon DNA packaged into virions.
Results
Replicative capacity of the ITR-flanked transgene cassette in pHLIRGN and pHLIRGN. 7 rep + hybrid amplicons
We tested the ability of Rep proteins and ITRs in hybrid amplicons to support the replication of the ITR-flanked transgene by cotransfecting Vero 2-2 cells with hybrid amplicon and HSV-1 helper DNA. Amplicons or hybrid amplicons (with and without the rep gene) transfected alone served as negative controls. Low-molecular-weight Hirt DNA was extracted 48 h after transfection and digested with Dpn I or Mbo I endonucleases, which have multiple cleavage sites in the amplicon DNA. Dpn I only recognizes DNA with both strands methylated, thereby eliminating input plasmid DNA, whereas Mbo I exclusively digests double-stranded DNA (dsDNA) with both strands unmethylated, thereby allowing us to determine the presence of de novo replicated DNA in transfected cells. Hemimethylated DNA is resistant to digestion by Dpn I and Mbo I. The DNA was fractionated by using either standard gel electrophoresis or pulsed field gel electrophoresis (PFGE) to separate high-molecularweight DNA and analyzed by Southern blotting with a 32 P-labeled GFP-specific probe (Figure 1 transducing units (t.u.)/ml after concentration. However, the presence of the rep gene in the amplicon pHLIRRed-N1 (see Materials and methods) or hybrid amplicon pHLIRGN lowered the titers by more than one order of magnitude, indicating that the large Rep proteins interfered with the replication and/or packaging process of the amplicons without and with the ITR sequences. This might be due to toxicity of Rep proteins, which compromises cell metabolism and/or ongoing replication of the ITR-flanked transgene with disruption of the continuity of the concatenates by Rep-mediated cleavage at trs or Rep binding at RBS within ITR sequences. Thus, we tested the integrity and size of hybrid amplicon and amplicon DNA packaged into virions by Southern blot hybridization. Amplicon DNA, in the presence of helper virus functions, is replicated in the form of a concatenate that is cleaved at an extending pac site when the virion capsid is full at a size of B150 kb. 34 Virion DNA was either undigested or digested with Asc I, which cleaves amplicon DNA once, and resolved on agarose gels by PFGE. In addition, virions of the rep + hybrid amplicon vector were also treated with DNase I to eliminate all DNA fragments not contained within and therefore protected by the virion. The blots with viral DNA were hybridized with Transgenic model for HSV/AAV-mediated, targeted integration JC Bakowska et al demonstrating that it was not incorporated into the virions (data not shown). The dimers of the ITR-flanked transgene cassette presumably are generated as byproducts during packaging of the rep + hybrid amplicon DNA and collected during concentration of the virions by contamination with small amounts of cellular debris.
Conformation and estimation of the copy number of the AAVS1 site in transgenic mice
The presence of the human AAVS1 locus in offspring of the transgenic founder mouse and its F2 offspring was determined by Southern blot analysis of DNA extracted from tails and digested with EcoR I or Pst I. Hybridization of genomic DNA from F2 mice, progeny of F1 mice heterozygous for the transgene, with the 1.4-kb 32 Plabeled fragment of the AAVS1 locus revealed either no band or bands of different intensities, which allowed hemizygous mice to be distinguished from homozygous mice (data not shown). In addition, the homozygous animals were outcrossed to wild-type mice, and DNA from progeny was screened by polymerase chain reaction (PCR) for the presence of the AAVS1 locus. This analysis revealed the presence of the transgene in all 11 offspring, confirming that the selected parents were homozygous for the AAVS1 site. In this homozygous line, the copy number of the human AAVS1 locus was estimated by Southern blot analysis using tail DNA that was digested with EcoR I or EcoR V and hybridized with the 32 P-labeled AAVS1 fragment. As a standard for gene copy number, serial dilutions of the cloned, full-length AAVS1 fragment were mixed with wild-type mouse DNA. An 8.2-kb fragment of high intensity was found in transgenic mouse genomic DNA after digestion with either enzyme, demonstrating that multiple copies of the human AAVS1 locus had been integrated in a head-totail tandem array ( Figure 3b ). This integration was found to be at a single site, as shown in Figure 7 . By using densitometric scanning of the autoradiograph shown in Figure 3b , we estimated that there were 10 copies of the AAVS1 locus in transgenic mice per diploid genome.
Stable integration frequency
Embryonic fibroblasts from AAVS1-transgenic mice were used to evaluate transgene integration after transduction with hybrid and standard amplicon vectors. Since primary embryonic fibroblasts undergo a quiescent phase after 10-14 passages, which would prevent colony evaluation, they were first allowed to undergo spontaneous immortalization by continuous propagation over a few months. This method of immortalization was chosen so as not to introduce any additional viral elements, such as E1a or SV40 T antigen, which have been shown to have an effect on expression levels of Rep proteins 35 and the excision of ITR-flanked cassettes. 36 
Integration of DNA sequences delivered by HLIGN and HSV.GN vectors
Only two GFP-positive clones each were obtained for these two vector types after transduction of AAVS1-bearing immortalized mouse embryonic fibroblasts with rep À or standard amplicon vectors. Genomic DNA from these four clones was digested with EcoR V or Nhe I, each of which cleaves the rep À hybrid amplicon and amplicon DNA once. Then the DNA was analyzed by Southern blot hybridization to determine whether the transgene had been integrated into the genome. As shown in Figure  5a , these clones had bands that hybridized with a GFPspecific probe. Two of the four clones, 2B and 1A ( Figure  5a ), showed an intense band of about 9 kb (the size of amplicon DNA). In addition, genomic DNA from clone 1A was analyzed by PFGE (Figure 5b ). The cells were placed into the agarose plugs and were undigested or digested with Swa I, which does not cut the rep À hybrid amplicon DNA. In the lane with the undigested DNA, the band that hybridized to a GFP probe was present Transgenic model for HSV/AAV-mediated, targeted integration JC Bakowska et al only at the level of well, confirming the integrated state of hybrid amplicon DNA (Figure 5b ). We also analyzed genomic DNA from clones derived from transduction of AAVS1-bearing mouse liver cell lines with rep À hybrid or standard amplicon vectors and found bands of varying intensities of about 9 kb that hybridized to a GFP probe in all examined clones (Figure 5c and d) . Taken together, these data demonstrate that in most cases the entire standard amplicon or rep À hybrid amplicon DNA integrates into the genome of transduced cells in the form of a concatenate of various sizes.
Site-specific integration of DNA sequences delivered by the HLIRGN vector
The transduction of AAVS1-bearing immortalized mouse embryonic fibroblasts with the rep + hybrid amplicon vector resulted in many stable GFP-positive clones. Genomic DNA from 10 randomly selected clones was digested with EcoR V or EcoR I and analyzed by Southern blots first using a GFP-specific probe and, after its removal, an AAVS1-specific probe to determine the proportion of site-specific and random integration events. EcoR V cleaves the rep + hybrid amplicon plasmid once (outside the ITR-flanked cassette; Figure 6a ) and the AAVS1 locus once (Figure 3 ), whereas EcoR I cleaves the rep + hybrid amplicon plasmid three times (outside the ITR-flanked cassette; Figure 6a ) and cleaves the AAVS1 locus at its far 5 0 and 3 0 ends ( Figure 1 ). Hybridization with a GFP probe revealed a single band in some clones (7, 9, 10, 11, 15) and multiple bands in other clones (8, 12, 13, 16, 17) . Thus, the GFP sequence integrated once to multiple times (Figure 6b ). When an AAVS1-specific probe was used, rearrangements of the AAVS1 sequence were detected in all clones except clone 7 ( Figure 6c ). Importantly, clones 8, 12, 13, 16, and 17 revealed bands that hybridized to both probes, which demonstrates the integration of the GFP sequence into the AAVS1 locus. These results were found in clones digested with either EcoR V or EcoR I (Figure 6b and c) . Overall, the site-specific integrations occurred in 30% of all genomic integration events in clones of transgenic mouse fibroblasts after transduction with the rep + hybrid amplicon vector.
In addition, fluorescence in situ hybridization (FISH) was performed to confirm the site-specific integration of the ITR-flanked cassette in AAVS1-bearing immortalized mouse fibroblasts in clone 17. Hybridization to both ITRcassette-and AAVS1-specific probes on a metaphase chromosome revealed that both sequences colocalized in the same region of the chromosome (Figure 7) , verifying the results from Southern blot analysis. The same probe did not hybridize to any sequences in wild-type mouse cells (data not shown).
To determine whether integration was limited to the ITR-flanked cassette or whether other sequences in the amplicon backbone were also integrated, PCR was used to detect the presence of the HSV pac sequence in genomic DNA from GFP-positive clones, and Southern blot analysis was used to detect the rep sequences. Among the five clones (7, 9, 10, 11, 15) that showed exclusively random integration of the GFP sequence, only two (7 and 10) showed the presence of HSV pac sequence (data not shown). All clones with site-specific integration, except 17, also showed integration at least at Transgenic model for HSV/AAV-mediated, targeted integration JC Bakowska et al one site other than the AAVS1 locus. Among the five clones (8, 12, 13, 16, 17) that showed site-specific integration of the GFP sequence, the HSV pac sequence was present in clones 12, 13, and 16 (data not shown). The rep sequence integrated only in clone 16 (data not shown), and the integration was in a site different from that of the site-specific integration of the transgene. More clones showed integration of the pac sequences than rep sequences, suggesting that the latter may have been selected against because of the toxicity of Rep proteins.
Discussion
We have generated and characterized a new line of transgenic mice that carries five full-length AAVS1 human sites (8.2 kb) at a single locus. Thus far, this is the largest AAVS1 sequence integrated into an animal genome that has been reported. We also found frequent site-specific integrations mediated by a rep + hybrid amplicon vector into this AAVS1 locus in a cell line derived from these transgenic mice. These latter findings extend previous work that showed AAVS1 site-specific integration mediated by this hybrid amplicon vector in two human cell lines. 33 We demonstrate for the first time the site-specific integrations of the ITR-flanked cassette mediated by rep + hybrid amplicon vector in transgenic mouse cell lines. We found the targeted integration in 50% of transgenic fibroblast clones, whereas other studies using rat transgenic fibroblasts found site-specific integration events in only 14% of clones derived from cells transfected with the AAV-based plasmid containing the rep gene. 28 Furthermore, we demonstrated for the first time the integrations of the entire amplicon sequences into the mammalian genome after cell transduction with rep À hybrid amplicon or standard amplicon vectors.
The AAVS1 site-specific integration of plasmids or viral vectors containing AAV ITRs into the host genome depends entirely on the presence of large Rep proteins. 17, 27 However, in human cells the frequency of targeted integration events varies from 94% after infec- Hybridization to a GFP-specific probe. Genomic DNA from GFP-positive clones and a control (C -genomic DNA from mock-infected cells) was digested with EcoR V and resolved by electrophoresis. DNA from clones 8, 12, 13, 16, and 17 was also digested with EcoR I. (c) Hybridization of the same membrane to an AAVS1-specific probe after removal of the GFP probe. Arrowheads indicate that the bands that hybridized to both the AAVS1 and GFP probes correspond to site-specific integration events and are depicted. Lane M: positions of the DNA molecular-weight markers.
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JC Bakowska et al tion with wild-type AAV 19 to 12% after transfection with rep + AAV-based plasmids. 37 In the present study, the frequency of site-specific integration in clones of the AAVS1-bearing transgenic mouse fibroblasts derived from transduction with rep + hybrid amplicon vector (50%) was much higher than in clones of transgenic rat fibroblasts transfected with plasmids containing the ITRs and the rep gene (14%). 28 This difference cannot be explained by the number of copies of the AAVS1 locus, because both transgenic rat and mouse lines carry a similar number (5 versus 7) of copies of this human site in a head-to-tail tandem sequence. Plausible explanations for the differences include the size of the AAVS1 fragment incorporated in transgenic animals (3.5 versus 8.2 kb), cytogenic location of the AAVS1 locus in the transgenic animals, and the status of fibroblasts (primary versus immortalized). In human cells, transduction of 293 cells with the rep + hybrid amplicon vector resulted in frequencies of site-specific integrations (30-40%) 32, 33 similar to the frequencies of these events reported when the same types of cells were transduced with plasmids containing the ITRs and the rep gene 38 or infected with hybrid baculovirus/AAV virus. 39 Overall, it is important to note that Rep proteins can interact with AAV ITRs within the hybrid concatenated amplicon dsDNA and the AAVS1 locus within the host cell genome to mediate site-specific integrations.
The final frequency of integration of the ITR-flanked transgene cassette into the AAVS1 site in murine transgenic fibroblasts is low and accounts for about 1% of cells infected with the rep + hybrid amplicon vector, as compared to 1% of infected cells with random integration events. Furthermore, the site-specific events frequently occurred together with random events in the same cell. Human 293 cells showed a similar frequency of site-specific integrations as compared to transgenic AAVS1 murine fibroblasts, while in human Gli36 AAVS1-specific integrations, events in infected cells were six times higher. 33 In contrast, the final frequency of sitespecific integrations in human bronchial cell line infected with wild-type AAV is about 57%. 19 The possible explanations for these differences may include specific cellular factors, the presence of structural AAV proteins, the expression levels of Rep proteins, or the presence of HSV virion proteins.
We observed that most clones of the AAVS1-bearing mouse fibroblasts derived from transduction with the rep + hybrid amplicon vector showed a single integration event of the transgene, whereas a few clones had two or three integration events. However, one clone that revealed the presence of rep sequences showed multiple integration events. Similar multiple transgene integrations were found in two clones of human 293 cells that were positive for the presence of rep sequences. 32 Importantly, in a few clones, multiple transgene integration events were not associated with the presence of the rep gene. 32, 33 At present, the mechanisms involved in these events are not known. Future experiments in different cell types should undertake temporal examination of the copy number of the transgene and expression of the rep gene in clones transduced with the rep + hybrid amplicon vector to determine the mechanisms of multiple integration events of the transgene.
In the AAVS1-bearing mouse fibroblasts, some sitespecific and random integrations were limited to the ITRflanked transgene cassette (excluding the amplicon backbone sequences) in stable clones derived from transduction with the rep + hybrid amplicon vector. Although random integrations are independent of expression of Rep proteins, 20, 29 Rep proteins might be involved in the excision of the ITR-flanked cassette from the concatenate of hybrid amplicon DNA, resulting in integrations limited to the ITR-flanked cassettes. Our results are in agreement with those of Wang et al, 33 who used this rep + hybrid amplicon vector in human cells and found in some clones with site-specific integrations the 4 kb (the size of ITR-flanked cassette) shift of AAVS1 bands suggesting that only the ITR cassette integrated. In another study, human 293 cells were transduced with hybrid amplicon vector expressing all four Rep proteins. In this case, the site-specific integrations were limited exclusively to the ITR-flanked cassette, whereas random integrations contained, in addition to a transgene cassette, amplicon backbone sequences. 32 It is unlikely that expression of the other two small Rep proteins could account for this difference, because among many studies using human cells transfected with plasmids expressing all Rep proteins, some have shown site-specific integration of the ITR-flanked cassette alone, 37 and others have shown site-specific integration of entire plasmid sequences. 17, 40 The state of the transgene in the host cell nucleus, delivered by standard HSV amplicon vectors, is under active investigation. It is thought that after cell transduction, concatenated amplicon sequences are present in an extrachromosomal state. 41 This probably explains why expression of transgenes from these vectors is lost over a few generations in dividing cells 8, 30 but is retained for months in nondividing cells. 31, 42, 43 However, even in a dividing cell population, a small portion of transduced who found that the GFP-positive clones derived from cells transduced with standard or rep À HSV/AAV hybrid amplicon vectors showed random integration of transgenes into the mammalian genome at low frequency. However, the latter study has not proven whether the backbone amplicon and rep À hybrid amplicon sequences also integrate into the host genome. In the present study, we demonstrated for the first time that not only the transgene but other backbone amplicon sequences were also integrated. In most clones that we examined, the entire amplicon or rep À hybrid amplicon DNA appears to have been incorporated into the genome as a concatenate of various sizes. Since no excision of the ITR-flanked cassette occurred before integration, it seems unlikely that HSV tegument and envelope proteins delivered into the cells with the virion have a role in the excision process. Similar types of amplicon integrations (JC Bakowska, unpublished data) occurred in the genome of cells transduced by using a version of the HSV/AAV hybrid amplicon vector that has only the D element from the ITRs and interrupted sequences of the rep gene and that prolongs the expression of transgenes in neurons 31 and hepatocytes. 8 The expression of Rep proteins in the hybrid amplicon vector increases the number of stably transduced cells. For example, in transgenic mouse embryonic fibroblasts bearing the human AAVS1 locus, the number of GFPexpressing clones was about 10-fold higher when cells were transduced with the rep + hybrid amplicon vector compared with the rep À hybrid or standard amplicon vectors. A similar effect of Rep proteins has been reported for human Gli36. 33 Taken together, these results indicate that the expression of Rep proteins in combination with AAV ITRs within concatenated hybrid amplicon DNA results in more integration events and hence more stable clones compared with the hybrid amplicon vector with ITRs alone.
This study describes a transgenic mouse line bearing five copies of an 8.2-kb region encompassing the human AAVS1 locus at a single site in the genome and demonstrates the site-specific integration of the transgene mediated by rep + HSV/AAV hybrid amplicon vectors. This mouse model can serve as a platform for targeted integration of ITR-flanked transgene cassettes in the presence of Rep proteins delivered by AAV and AAV hybrid vectors, with HSV/AAV hybrid amplicons that have the capacity to carry large and multiple transgenes. Further, the ITR-flanked transgene cassette can replicate as an independent unit in the presence of HSV helper virus functions within the hybrid amplicon plasmid and possibly the hybrid amplicon vector, thus providing a means of pruning away of backbone amplicon sequences and transgene amplification prior to integration. Together this AAVS1-transgenic mouse line and AAVderived vectors will facilitate analysis of site-specific integration events in primary cells in culture and in vivo. We are currently testing the functional recovery as well as targeted integration events of specific genes delivered by the rep + hybrid amplicon vector in primary cell culture and in vivo using mouse models of hereditary human diseases that also carry the human AAVS1 locus.
Materials and methods

Amplicon plasmid constructs
The HSV/AAV hybrid amplicons, pHLIRGN, pHLIGN, and pHSVLGN, used in these experiments have been described previously. 33 We deliberately chose to use the rep + hybrid amplicon tested previously in human cell lines 33 in order to draw a direct comparison of the nature of transgene integration mediated by this vector in transgenic mouse cells versus human cells. In addition to containing the origin of replication and pac signal from HSV-1 virus and the procaryotic plasmid sequences, these amplicons contain a transgene cassette that consists of the enhanced GFP gene driven by the human cytomegalovirus (CMV) immediate-early promoter and the neomycin resistance gene (neo r ) driven by the SV40 promoter. In the pHLIRGN hybrid amplicon, the transgene cassette (4.2 kb) is flanked by AAV ITRs, and the AAV rep 68/78 gene, which is under its cognate promoter, p5, is located downstream of the 3 0 ITR. The ITR-flanked cassette is flanked on each side by loxP sites. The pHLIGN hybrid amplicon has a parallel construction but lacks the rep gene, and the pHSVLGN amplicon lacks the ITRs and rep gene. The pHSV.GN amplicon contains the same transgene cassette as pHSVLGN but lacks the loxP sites. 8 To construct a rep + hybrid amplicon with a 7.1-kb transgene cassette flanked by AAV ITRs, a 2.9-kb Mlu I fragment from p5173 (provided by Dr R Wade-Martins, Massachusetts General Hospital, Charlestown, MA, USA) was subcloned into the Mlu I site at the 5 0 end of the CMV promoter of pHLIRGN to generate pHLIRGN.7.
The amplicon plasmid, pHLIRRed2-N1, which contains the rep gene but no ITR sequences or the ITRflanked transgene cassette, was derived from pHLIRGN by digestion with Not I and Sgf I, which removes the entire ITR-flanked cassette including the 3 0 and 5 0 ITRs. This amplicon backbone was subsequently ligated with a PCR-derived expression cassette from pdsRed2-N1 (Invitrogen, Carlsbad, CA, USA), which consists of the gene encoding the red fluorescence protein (RFP), which is controlled by the CMV promoter, followed by a polyadenylation signal.
Packaging of amplicon DNA into HSV-1 virions and titration of vectors
We packaged amplicon DNA by using a helper virus-free packaging system that utilizes a pac-deleted, ICP27-deleted, oversized HSV-1 genome in a bacterial artificial chromosome (fHSVDpacD27 0+), as described by Saeki et al. 5 The titers of HSVLGN and HLIGN vectors were in the range of 1-3 Â 10 8 t.u./ml, whereas the titers of HLIRGN and HLIRRed2-N1 vectors were in the range of 0.9-1.0 Â 10 7 t.u./ml.
Generation of transgenic mice
An 8.2-kb human genomic fragment containing the entire AAVS1 locus 13 was used for microinjection after digestion of the plasmid pRIA-N3 (gift from Dr R Kotin, NIH) with EcoR I. The 8.2-kb DNA band was extracted from the gel, purified, and microinjected into fertilized oocytes of B6C3F1 mice, and the eggs were implanted into the uterus of pseudopregnant foster mothers. A total PCR assay for the AAVS1 sequence in genomic DNA
The presence of the AAVS1 sequence in transgenic mice was determined by PCR. Genomic DNA (1 mg) was used as a substrate with the specific primer pair 5 0 -GCA GTC TGC TAT TCA TCC CCT TTA CGC G-3 0 and 5 0 -CCA GGG TGT GCT GGG CAG GTA GC-3 0 , which generates a 250-bp fragment of AAVS1 sequence. The reaction mixture was first incubated for 4 min at 941C and then subjected to 35 cycles of PCR amplification for 1 min at 941C, 45 s at 581C, and 30 s at 721C. The final extension was carried out for 5 min at 721C. The amplified products were electrophoresed on a 1.5% agarose gel with ethidium bromide.
PCR assay for the HSV pac sequence in genomic DNA PCR was used to determine the presence of the HSV pac sequence in AAVS1-bearing mouse embryonic fibroblast clones stably transduced with HSV.GN, HLIGN, and HLIRGN vectors. Genomic DNA (1 mg) was used as a substrate with the specific primer pair 5 0 -GTT ACC TGG GAC TGT GCG GTT GGG-3 0 and 5 0 -CCG AGA CTA GCG AGT TAG ACA GGC A-3 0 , which generates a 180-bp fragment of HSV pac sequence. The reaction mixture was first incubated for 4 min at 941C and then subjected to 35 cycles of PCR amplification for 1 min at 941C, 45 s at 561C, and 30 s at 721C. The final extension was carried for 5 min at 721C. The amplified products were electrophoresed on a 1.5% agarose gel with ethidium bromide.
Immortalization of mouse embryonic fibroblasts
Primary mouse fibroblasts were prepared from fetuses homozygous for the AAVS1 locus at embryonic day 13.5 using standard procedures. 44 Briefly, embryos were rinsed in phosphate-buffered saline (PBS), decapitated, placed in trypsin-EDTA, and then cut into small pieces with a sterile blade. The tissues were dissociated by incubation in trypsin-EDTA for 15 min at 371C. After incubation, the cells were centrifuged at 1000 Â g for 5 min at 101C, resuspended in DMEM supplemented with 10% fetal calf serum (FCS) and 1% penicillin-streptomycin (Invitrogen, Carlsbad, CA, USA), and transferred to a T-175 flask (Falcon). After 24 h, the cellular debris was removed and fresh medium was added.
Immortalized mouse embryonic fibroblasts (MEF) were established by using the protocol described by Todaro and Green. 45 Every 3 days, starting at passage 4, cells were counted and seeded in growth medium at a density of 3 Â 10 5 cells per 6-cm plate. The medium was changed 1 day after seeding the cells. Immortalization of the cells was obtained after passage 26, when a six-fold increase in the number of cells occurred over a 3-day period.
Liver cell line carrying the AAVS1 locus
The liver cell line, TIB-73 (ATCC, Manassas, VA, USA), was cotransfected with an RIA-N3 plasmid (the same plasmid used for generating transgenic mice) containing an 8.2-kb AAVS1 locus and a pBS TK/hygromycin plasmid containing the hygromycin resistance gene. Single-cell clones were selected with 0.3 mg/ml hygromycin and expanded, and the presence of the AAVS1 locus was confirmed by Southern blot analysis. The AAVS1-bearing cells were transduced with HSV.GN and HLIGN vectors, replated 48 h later, and grown in the presence of 0.4 mg/ml G418. The selected clones were expanded, and genomic DNA was digested with an enzyme that cuts the amplicon and rep À hybrid amplicon DNA once.
Transduction efficiency
Immortalized MEF-AAVS1 cells were infected with HLIRGN, HLIGN, HSVLGN, or HSV.GN amplicon vectors at passages in the range of 30-35. The fibroblasts were plated at a density of 3 x 10 5 cells per 6-cm plate 1 day before infection and were infected at an MOI of 1 the following day. After incubation for 4 h at 371C, the cells were washed with growth medium and incubated with fresh growth medium for 44 h. Then cells were resuspended with trypsin-EDTA. Half of these cells were subjected to FACS analysis for GFP expression, and the other half were seeded at low densities (1 Â 10 Transduction efficiency refers to the number of GFPpositive cells per total number of cells, as determined by FACS analysis 48 h after infection. Stable integration frequency (SIF) refers to the number of stable GFPexpressing colonies obtained relative to the number of initially transduced, GFP-expressing cells determined 2 weeks after seeding the infected cells. One-way analysis of variance was used to determine the overall effect of vectors on SIF; Scheffe's post hoc test was applied for subsequent pairwise comparisons. The alpha level considered significant was Po0.05.
Assay of ITR-flanked cassette replication
To evaluate the replication capability of the ITR-flanked transgene cassette in hybrid amplicons, pHLIRGN.7, pHLIRGN, and pHLIGN, as well as the standard amplicon pHSVLGN, were cotransfected into Vero 2-2 cells with the F-plasmid, fHSVDpacD27 0+, which served as a helper virus genome. At 48 h after transfection, the low-molecular-weight DNA was recovered from cells using the Hirt method 46 with slight modifications. Briefly, the cells in a 6-cm plate were lysed by adding 0.5 ml of a solution of 0.6% SDS, 10 mM EDTA (pH 7.5) for 20 min at room temperature. Then the lysate was scraped into a microcentrifuge tube and mixed with 125 ml of 5 M NaCl and incubated overnight at 41C. The following day the extract was centrifuged at 17 000 Â g at 41C for 30 min. The supernatant was recovered and extracted with phenol, phenol-chloroform, and chloroform. Low-molecular-weight DNA was precipitated with isopropanol, rinsed with 70% ethanol, and dissolved in 35 ml of TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0). The DNA was undigested or digested with Dpn I or Mbo I (New England BioLabs, Beverly, MA, USA) and Transgenic model for HSV/AAV-mediated, targeted integration JC Bakowska et al separated on a 1% agarose gel using PFGE or standard electrophoresis. Southern blot analysis was carried out with a 0.7-kb GFP-specific DNA probe that was derived from pHSVGN by cutting with Pme I and labeled with [g-32 P]-CTP using a random priming kit (DECAprime II; Ambion, Austin, TX, USA).
Resolution of virion-packaged DNA by PFGE
Amplicon and hybrid amplicon virions were resuspended in PBS at a concentration of 10 4 t.u./ml. One preparation of rep + hybrid amplicon virions was treated with 15 ml of DNase I (Gentra Systems, Minneapolis, MN, USA). After incubation at 371C for 30 min, the enzyme was inactivated at 681C for 15 min. A 2% solution of lowmelting agarose (InCert Agarose, FMC, Rockland, ME, USA) was melted in PBS, cooled to 501C, and added to an equal volume of resuspended amplicon virions. The mixture was poured into a plastic block forming mold (Bio-Rad, Hercules, CA, USA) and placed on ice for 10 min. After the agarose blocks solidified, they were removed from the mold, placed in a solution consisting of 0.5 M EDTA, 1% SDS, with 0.05 mg/ml proteinase K, and incubated for 16 h at 501C to digest the virion envelopes and capsids. Then the agarose blocks were washed twice in TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 7.5) at room temperature and stored at 41C. Digestion of DNA in agarose blocks with Asc I was carried out as recommended by the manufacturer (New England BioLabs, Beverly, MA, USA). Agarose blocks containing DNA from virions (digested with Asc I or undigested) were loaded into 1% agarose gel (SeaKem CTC agarose), and PFGE was performed using a CHEF II apparatus (Bio-Rad) at 200 V at 141C in 0.5 Â TBE buffer (10 mM Tris, 1 mM boric acid, 1 mM EDTA, pH 8.3).
Southern blot analysis of DNA from stable clones
Total genomic DNA was isolated from stable GFPpositive mouse AAVS1 fibroblast clones previously transduced with the HSV.GN, HLIGN, and HLIRGN vectors using a standard protocol. 47 Genomic DNA (10 mg) was digested with 30 U of EcoR I or EcoR V for 16 h at 37 o C. The digested DNA was electrophoresed on a 0.75% agarose gel and blotted onto a nylon membrane (Hybond N+; Amersham Pharmacia Biotech, Piscataway, NJ, USA) by capillary transfer. After prehybridization for 2 h at 65 o C, the membrane was hybridized to DNA probes labeled with [g-32 P]-CTP in a buffer consisting of 6 Â SSC, 0.1% SDS, 1 Â Denhardt's solution with 100 mg/ ml salmon sperm DNA for 16 h at 651C. After hybridization, the membrane was washed with 2 Â SSC (1 Â SSC¼0.15 M NaCl and 0.015 M sodium citrate) at room temperature and then in decreasing concentrations of SSC (1 Â , 0.5 Â , 0.1 Â ) for 30 min each at 651C. To determine site-specific integration events, a membrane was first hybridized with a labeled 0.7-kb GFP-specific DNA probe and exposed to Kodak X-ray film with an intensifying screen for 3-7 days. Then the probe was removed by boiling the membrane in 0.1 Â SSC for 10 min, and the same membrane was hybridized with a labeled 1.4-kb AAVS1-DNA-specific probe derived from pRVK (from Dr K Berns, Cornell Medical School, New York, NY, USA) by cutting with Pst I, and once more exposed to Kodak X-ray film. To determine the integration of rep sequences, the membrane was hybridized with a labeled 0.83-kb rep-specific DNA probe derived from pSSV9 (from Dr J Samulski, University of North Carolina, NC, USA).
PCR assay for HSV pac sequence in genomic DNA
The presence of HSV pac sequence in AAVS1-carrying mouse embryonic fibroblast clones transduced with HSV.GN, HLIGN, and HLIRGN vectors was determined by PCR. Genomic DNA (1 mg) was used as a substrate with specific primer pair 5 0 -GTT ACC TGG GAC TGT GCG GTT GGG-3 0 and 5 0 -CCG AGA CTA GCG AGT TAG ACA GGC A-3 0 , which generates a 180-bp fragment of HSV pac sequence. The reaction mixture was first incubated for 4 min at 941C and then subjected to 35 cycles of PCR amplification for 1 min at 941C, 45 s at 561C, and 30 s at 721C. The final extension was carried for 5 min at 721C. The amplified products were electrophoresed on a 1.5% agarose gel with ethidium bromide.
Fluorescence in situ hybridization
A 3.8-kb DNA fragment corresponding to the entire transgene cassette (GFP and Neo r genes driven by CMV and SV40 promoters, respectively) and an 8.2-kb AAVS1 DNA fragment were labeled by nick translation with SpectrumGreen-dUTP and SpectrumRed-dUTP, respectively, according to the manufacturer's protocol (Vysis, Downers Grove, IL, USA). The metaphase chromosome spreads, from a selected stable clone 17 and from wildtype mouse, cells were prepared according to standard cytogenetic techniques. 48 Clone 17 was derived from transduction with an HLIRGN amplicon vector. Before hybridization, the slides with cytogenetic preparations were washed in 2 Â SSC for 30 min at 371C, dehydrated in an ethanol series (cold 70%, 80%, and room temperature 90%, 100%), denatured for 2 min in 50% formamide solution (formamide dissolved in 2 Â SSC) at 721C, and again dehydrated in the same ethanol series. The probes were mixed with 10 mg of human Cot-1 DNA, precipitated with ethanol, and resuspended in hybridization buffer (50% formamide, 2 Â SSC, 10% dextran sulfate) to a concentration of 12 ng/ml. Before hybridization, the probe was denatured at 721C for 10 min and incubated at 371C for 10 min to allow preannealing of repeated sequences. Then, 20 ml of hybridization solution was applied to each slide, which was covered with a plastic coverslip and sealed with rubber cement to prevent evaporation. The slides were placed in a moist chamber and incubated at 371C for 18 h. After hybridization, the slides were immersed in 2 Â SSC to remove coverslips and washed in 0.4 Â SSC with 0.3% NP-40 at 721C for 2 min. The nuclei were counterstained with 4, 6-diamidino-2-phenylindole (DAPI), and the slides were coverslipped and examined using an epifluorescence microscope.
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